AXIM BIOTECHNOLOGIES, INC. Amortization of Debt Issuance Costs
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Amortization of Debt Issuance Costs of $459.52 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-04-16
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for the quarter ending 2023-12-31 was $209.52K.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for the quarter ending 2023-09-30 was -$575.00K.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for the quarter ending 2023-06-30 was $575.00K.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for the quarter ending 2023-03-31 was $250.00K, a 81.13% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for fiscal 2023 was $459.52K.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for fiscal 2021 was $100.00K.
- AXIM BIOTECHNOLOGIES, INC. amortization of debt issuance costs for fiscal 2020 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $209.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$365.48K derived: sum of 2 quarters · filed 2024-04-16 | $209.52K derived: sum of 3 quarters · filed 2024-04-16 | $459.52K 10-K · filed 2024-04-16 |
| 2023-09-30 | -$575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $250.00K 10-Q · filed 2023-11-20 | -$1.07M derived: sum of 4 quarters · filed 2023-11-20 |
| 2023-06-30 | $575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $825.00K 10-Q · filed 2023-08-21 | -$500.00K derived: sum of 3 quarters · filed 2023-08-21 | -$500.00K derived: sum of 4 quarters · filed 2023-11-20 |
| 2023-03-31 | $250.00K 10-Q · filed 2023-05-22 | -$1.07M derived: sum of 2 quarters · filed 2023-05-22 | -$1.07M derived: sum of 3 quarters · filed 2023-11-20 | -$1.07M derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$1.32M derived: sum of 2 quarters · filed 2023-11-20 | -$1.32M derived: sum of 3 quarters · filed 2023-11-20 | $0.00 10-K · filed 2023-04-17 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $1.32M 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $1.32M 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $1.32M 10-Q · filed 2023-05-22 | |||
| 2021-12-31 | $100.00K 10-K · filed 2023-04-17 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2022-04-19 |